Exploring Medicinal Plants and Phytochemicals for Telomere Maintenance and Anti-aging: Insights into Telomerase Activation and Longevity
Revista Brasileira de Farmacognosia,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 11, 2025
Language: Английский
An open-label, single dose, safety and pharmacokinetic study of Withania somnifera root extract in healthy volunteers
Eshita Sharma,
No information about this author
Gayatri Ganu,
No information about this author
Ketan Kshirsagar
No information about this author
et al.
Drug Metabolism and Personalized Therapy,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 18, 2025
Abstract
Objectives
Withania
somnifera
(WS),
also
known
as
Ashwagandha,
is
a
health-beneficial
Ayurvedic
medicinal
plant
with
great
potential
an
adaptogen
rejuvenating
and
anti-aging
effects.
However,
studies
investigating
pharmacokinetics
(PK),
safety,
tolerability
of
WS
on
humans
are
limited.
The
present
study
evaluated
PK,
root
extract
(2.5
%
total
withanolides)
capsules
upon
oral
administration
two
200
mg
each
(total
400
mg)
in
healthy
male
female
volunteers.
Methods
An
open
label,
single
dose,
clinical
design
comprising
volunteers
was
employed.
PK
parameters
the
four
bioactive
constituents
viz.
withanoside
IV,
withaferin
A,
12-deoxy-withastramonolide,
withanolide
A
after
analysis
plasma
using
validated
UHPLC-MS/MS
method.
Further,
safety
assessment
for
vital
signs,
testing
organ
function,
urine
examination,
X-ray,
ECG,
well
adverse
events
profile
were
investigated.
Results
After
2
(200
each),
participants
reported
normal
physical,
hematological,
biochemical
no
abnormalities
metrics.
For
bioactives,
exposure
range
between
0.472
4.468
ng/mL
(C
max
),
1.000–1.416
h
(T
2.051–13.319
ng/mL*h
(AUC
0-t).
t
1/2
(1.696–4.377
h),
lambda_z
(0.141–0.282
L/h),
Cl/F
(0.065–0.954
mg/(ng/ml)/h),
AUMC
0-inf_obs
(21.720–80.485
ng/mL*hˆ2)
MRT
(3.680–7.516
h)
differed
bioactive.
Conclusions
elucidated
showed
that
may
safely
consume
at
dose
(2
without
any
harmful
Language: Английский
Effects of a natural ingredients-based intervention targeting the hallmarks of aging on epigenetic clocks, physical function, and body composition: a single-arm clinical trial
Natàlia Carreras-Gallo,
No information about this author
Rita Dargham,
No information about this author
Shealee P. Thorpe
No information about this author
et al.
Aging,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 14, 2025
Aging
interventions
have
progressed
in
recent
years
due
to
the
growing
curiosity
about
how
lifestyle
impacts
longevity.
This
study
assessed
effects
of
SRW
Laboratories'
Cel
System
nutraceutical
range
on
epigenetic
methylation
patterns,
inflammation,
physical
performance,
body
composition,
and
biomarkers
aging.
A
1-year
was
conducted
with
51
individuals,
collecting
data
at
baseline,
3
months,
6
12
months.
Participants
were
encouraged
walk
10
minutes
practice
5
mindfulness
daily.
Significant
improvements
muscle
strength,
function,
composition
metrics
observed.
Epigenetic
clock
analysis
showed
a
decrease
biological
age
significant
reductions
stem
cell
division
rates.
Immune
subset
indicated
changes,
increases
eosinophils
CD8T
cells
decreases
B
memory,
CD4T
T-regulatory
cells.
Predicted
biomarker
proxies
(EBPs)
changes
retinol/TTHY,
regulator
growth,
proliferation,
differentiation,
deoxycholic
acid
glucuronide
levels,
metabolite
generated
liver.
Gene
ontology
revealed
CpG
genes
involved
critical
processes
related
aging,
such
as
oxidative
stress-induced
premature
senescence,
pyrimidine
deoxyribonucleotide
metabolic
process,
TRAIL
binding,
hyaluronan
biosynthetic
neurotransmitter
loading
into
synaptic
vesicles,
pore
complex
assembly,
collagen
protein
phosphatase
2A
binding
activity,
activation
transcription
factor
binding.
Our
findings
suggest
that
supplement
may
effectively
reduce
improve
health
metrics,
warranting
further
investigation
its
mechanistic
pathways
long-term
efficacy.
Language: Английский
Systems pharmacology of phytochemical anacardic acid in the chemoprevention of hepatocellular carcinoma
Drug Metabolism and Personalized Therapy,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 22, 2025
Abstract
Objectives
Hepatocellular
carcinoma
(HCC)
is
a
common
type
of
liver
cancer
that
progresses
quickly
and
has
limited
treatment
options.
Nutraceutical
anacardic
acid
(AA),
bioactive
compound
derived
from
cashew
nut
shell,
emerged
as
potential
candidate
for
HCC
owing
to
its
reported
anti-inflammatory,
anticancer
diverse
pharmacological
properties.
In
the
present
study,
we
investigate
AA
an
inhibitor
using
molecular
docking,
gene
ontology,
network
pharmacology.
Methods
The
pharmacokinetic
physicochemical
properties
were
assessed
Swiss
ADME.
SuperPred,
Similarity
Ensemble
Approach,
ChEMBL
Target
Prediction
online
tools
used
determining
targets
AA.
addition,
GeneCards,
NCBI,
DisGeNET
UniProt
ID
search
top
25
hub
genes
determined
Cytohubba
plugin.
A
protein
interaction
(PPI)
was
constructed
through
STRING
database.
Gene
Ontology
(GO)
biological
process
Kyoto
Encyclopaedia
Genes
(KEGG)
pathway
enrichment
analysis
performed
FunRich
ShinyGO
0.77.
Moreover,
docking
studies
on
NF-κB
GSK-3β.
expression
levels
also
validated
by
western
blotting.
Results
Comprehensive
data
identified
375
11,333
HCC,
with
264
in
common.
Network
key
targets,
including
caspase-3,
NF-κB.
ontology
topology
highlighted
essential
pathways
implicated
progression
such
renin-angiotensin
system,
VEGF
signalling,
apoptosis.
Molecular
revealed
strong
binding
affinity
proteins
Upregulation
p-NRF2
p-GSK-3β,
downregulation
p-NF-κB
caspase-1
Conclusions
Taken
together,
our
study
highlights
promising
chemopreventive
agent
because
significant
modulatory
effects
important
regulatory
linked
cell
division,
inflammation,
apoptosis,
antioxidant
response.
Language: Английский
The Impact of a Natural Ingredients based Intervention Targeting the Nine Hallmarks of Aging on DNA methylation
Natàlia Carreras-Gallo,
No information about this author
Rita Dargham,
No information about this author
Shealee P. Thorpe
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 3, 2024
Aging
interventions
have
progressed
in
recent
years
due
to
the
growing
curiosity
about
how
lifestyle
impacts
longevity.
This
study
assessed
effects
of
SRW
Laboratories
Cel1,
Cel2,
and
Cel3
(Cel
System)
nutraceutical
range
on
epigenetic
methylation
patterns,
inflammation,
physical
performance,
body
composition,
biomarkers
aging.
A
1-year
was
conducted
with
51
individuals,
collecting
data
at
baseline,
3
months,
6
12
months.
Participants
were
encouraged
walk
10
minutes
practice
5
mindfulness
daily.
Significant
improvements
muscle
strength,
function,
composition
metrics
observed.
Epigenetic
clock
analysis
showed
a
decrease
biological
age
significant
reductions
stem
cell
division
rates.
Immune
subset
indicated
changes,
increases
eosinophils
CD8T
cells
decreases
B
memory,
CD4T
T-regulatory
cells.
Predicted
biomarker
proxies
(EBPs)
changes
retinol/TTHY,
regulator
growth,
proliferation,
differentiation,
deoxycholic
acid
glucuronide
levels,
metabolite
generated
liver.
Gene
ontology
revealed
CpG
genes
involved
critical
processes
related
aging,
such
as
oxidative
stress-induced
premature
senescence,
pyrimidine
deoxyribonucleotide
metabolic
process,
TRAIL
binding,
hyaluronan
biosynthetic
neurotransmitter
loading
into
synaptic
vesicles,
pore
complex
assembly,
collagen
protein
phosphatase
2A
binding
activity,
activation
transcription
factor
binding.
Our
findings
suggest
that
Cel
System
supplement
may
effectively
reduce
improve
health
metrics,
warranting
further
investigation
its
mechanistic
pathways
long-term
efficacy.
Language: Английский
Acute and sub-chronic oral GLP toxicity of Withania somnifera root extract in Sprague Dawley rats
Pralhad Wangikar,
No information about this author
Pradhnya Chaudhari,
No information about this author
Eshita Sharma
No information about this author
et al.
Drug Metabolism and Personalized Therapy,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 1, 2024
Abstract
Objectives
Withania
somnifera
(WS)
is
a
valuable
medicinal
plant
that
has
been
used
against
several
ailments.
The
properties
of
WS
are
ascribed
to
existence
secondary
metabolites
which
in
great
demand
herbal
nutraceutical
industry.
Despite
well-known
therapeutic
effects
WS,
it
necessary
assess
preclinical
toxicity
on
rats
and
further
explore
its
potential
application
treatment
various
disorders
humans.
existing
study
assessed
oral
acute
sub-chronic
toxicities
root
extract
Sprague
Dawley
(SD)
(male
female)
for
14
90
days,
respectively
under
OECD-423
-408
guidelines
as
well
GLP
compliance.
Methods
In
toxicity,
either
sex
were
orally
fed
dose
2,000
mg/kg.
animals
administered
repeated
doses
at
250,
500,
1,000
mg/kg
days
with
an
additional
14-day
recovery
period.
Two
more
groups
(n=5
each)
receiving
vehicle
also
observed.
Results
the
results
revealed
LD
50
SD
was
higher
than
administration
showed
no
significant
toxicological
changes
rats.
Haematological
serum
chemistry
markers
found
within
normal
range.
Terminal
necropsy
gross
or
histopathological
outcomes.
Conclusions
no-observed-adverse-effect
level
(NOAEL)
body
weight,
safe
use
this
Language: Английский
Acute and sub-chronic oral GLP toxicity of Withania somnifera root extract in Sprague Dawley rats
Pralhad Wangikar,
No information about this author
Pradhnya Chaudhari,
No information about this author
Eshita Sharma
No information about this author
et al.
Drug Metabolism and Personalized Therapy,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 30, 2024
Abstract
Objectives
Withania
somnifera
(WS)
is
a
valuable
medicinal
plant
that
has
been
used
against
several
ailments.
The
properties
of
WS
are
ascribed
to
existence
secondary
metabolites
which
in
great
demand
herbal
nutraceutical
industry.
Despite
well-known
therapeutic
effects
WS,
it
necessary
assess
preclinical
toxicity
on
rats
and
further
explore
its
potential
application
treatment
various
disorders
humans.
existing
study
assessed
oral
acute
sub-chronic
toxicities
root
extract
Sprague
Dawley
(SD)
(male
female)
for
14
90
days,
respectively
under
OECD-423
-408
guidelines
as
well
GLP
compliance.
Methods
In
toxicity,
either
sex
were
orally
fed
dose
2,000
mg/kg.
animals
administered
repeated
doses
at
250,
500,
1,000
mg/kg
days
with
an
additional
14-day
recovery
period.
Two
more
groups
(n=5
each)
receiving
vehicle
also
observed.
Results
the
results
revealed
LD
50
SD
was
higher
than
administration
showed
no
significant
toxicological
changes
rats.
Haematological
serum
chemistry
markers
found
within
normal
range.
Terminal
necropsy
gross
or
histopathological
outcomes.
Conclusions
no-observed-adverse-effect
level
(NOAEL)
body
weight,
safe
use
this
Language: Английский
Molecular Insights into the Inhibition of Lipid Accumulation in Hepatocytes by Unique Extracts of Ashwagandha
Dongyang Li,
No information about this author
Hanlin Han,
No information about this author
Yixin Sun
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(22), P. 12256 - 12256
Published: Nov. 14, 2024
We
investigated
the
effect
of
purified
withanolides
and
extracts
derived
from
Ashwagandha
on
steatosis,
abnormal
accumulation
fat
that
can
lead
to
non-alcoholic
fatty
liver
disease
(NAFLD).
Collaborator
ARF
(CARF,
also
known
as
CDKN2AIP,
a
protein
regulates
hepatic
lipid
metabolism,
buildup,
damage)
was
used
an
indicator.
Six
(Withaferin
A,
Withanone,
Withanolide
B,
Withanoside
IV,
V,
Withanostraminolide-12
deoxy)
reversed
decrease
in
CARF
caused
by
exposure
free
acids
(FFAs)
liver-derived
cells
(HepG2
hepatocytes).
After
analyzing
effects
these
mRNA
levels,
FFA
accumulation,
aggregation,
oxidative
DNA
damage
stresses,
we
selected
Withaferin
A
Withanone
for
molecular
analyses.
Using
palmitic-acid-induced
acid
stress
model
Huh7
cells,
found
significant
reduction
activity
key
regulators
lipogenesis
pathways,
including
sterol
regulatory
element-binding
protein-1c
(SREBP-1c),
synthase
(FASN),
peroxisome
proliferator-activated
receptors
(PPARγ
PPARα).
This
vitro
study
suggests
low,
non-toxic
doses
or
containing
possess
anti-steatosis
antioxidative-stress
properties.
Further
vivo
clinical
studies
are
required
investigate
therapeutic
potential
Ashwagandha-derived
bioactive
ingredients
NAFLD.
Language: Английский